Filing Details

Accession Number:
0001209191-15-024125
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-03-09 16:51:14
Reporting Period:
2015-03-05
Filing Date:
2015-03-09
Accepted Time:
2015-03-09 16:51:14
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1593034 Endo International Plc ENDP Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1179357 B Caroline Manogue C/O Endo International Plc
Minerva House, Simmonscourt Road
Ballsbridge, Dublin 4 L2
Exec. V.p.,Chief Legal Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Ordinary Shares Acquisiton 2015-03-05 42,033 $19.93 85,133 No 4 M Direct
Ordinary Shares Disposition 2015-03-05 42,033 $87.78 43,100 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Ordinary Shares 2007 Stock Incentive Plan Stock Options (NQ) Disposition 2015-03-05 42,033 $0.00 42,033 $19.93
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2019-02-26 No 4 M Direct
Footnotes
  1. This represents the average price at which Ms. Manogue's ordinary shares were sold on March 5, 2015.
  2. Ms. Manogue's stock options that were granted under the 2007 Stock Incentive Plan on February 26, 2009 were generally exercisable 25% per year on each of February 26, 2010, February 26, 2011, February 26, 2012, and February 26, 2013.
  3. These securities were granted to Ms. Manogue in consideration of her services as the Executive Vice President, Chief Legal Officer of the registrant.